[1] Umesawa, M., & Kobashi, G. (2017). Epidemiology of hypertensive disorders in pregnancy: Prevalence, risk factors, predictors and prognosis. Hypertension Research, 40(3), 213–220.
https://doi.org/10.1038/hr.2016.126
[2] Hutcheon, J. A., Lisonkova, S., & Joseph, K. S. (2011). Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy. Best Practice & Research Clinical Obstetrics & Gynaecology, 25(4), 391–403.
https://doi.org/10.1016/j.bpobgyn.2011.01.006
[3] Mustapha, W. M., Sadique, S., Nabiee, R., & Mustapha, W. M. (2012). A comprehensive review of hypertension in pregnancy. Journal of Pregnancy, 2012, 105918.
https://doi.org/10.1155/2012/105918
[4] Marić, I., Tsur, A., Aghaeepour, N., Montanari, A., Stevenson, D. K., Shaw, G. M., & Winn, V. D. (2017). Cluster analysis to estimate the risk of preeclampsia in the high-risk Prediction and Prevention of Preeclampsia and Intrauterine Growth Restriction (PREDO) study. PLoS ONE, 12(3), e0174399.
https://doi.org/10.1371/journal.pone.0174399
[5] Kenny, L. C., Broadhurst, D. I., Dunn, W., Brown, M., North, R. A., McCowan, L., Roberts, C., Cooper, G. J. S., Kell, D. B., & Baker, P. N. (2010). Robust early pregnancy prediction of later preeclampsia using metabolomic biomarkers. Hypertension, 56(4), 741–749.
https://doi.org/10.1161/HYPERTENSIONAHA.110.157297
[6] Hasan, S. M. A., Hassan, M., Saha, S., Islam, M., Billah, M., & Islam, S. (2016). Dietary phytate intake inhibits the bioavailability of iron and calcium in the diets of pregnant women in rural Bangladesh: A cross-sectional study. BMC Nutrition, 2, 44.
https://doi.org/10.1186/s40795-016-0064-8
[7] Rayman, M. P., Bath, S. C., Westaway, J. A. F., Williams, P., Mao, J., Vanderlelie, J. J., Perkins, A. V., & Redman, C. W. G. (2015). Selenium status in UK pregnant women and its relationship with hypertensive conditions of pregnancy. British Journal of Nutrition, 113, 249–258.
https://doi.org/10.1017/S000711451400364X
[8] Romano, M. E., Hawley, N. L., Eliot, M. N., Calafat, A. M., Jayatilaka, N. K., Kelsey, K. T., McGarvey, S. T., Phipps, M. G., Savitz, D. A., Werner, E. F., & Braun, J. M. (2017). Variability and predictors of urinary concentrations of organophosphate flame retardant metabolites among pregnant women in Rhode Island. Environmental Health, 16, 40.
https://doi.org/10.1186/s12940-017-0247-z
[9] Wilson, K. L., Casey, B. M., McIntire, D. D., Halvorson, L. M., & Cunningham, F. G. (2012). Subclinical thyroid disease and the incidence of hypertension in pregnancy. Obstetrics & Gynecology, 119, 315–320.
https://doi.org/10.1097/AOG.0b013e318240de6a
[10] Amin, S., Agarwal, K., & Beg, R. (2013). Genetic neural network-based data mining in prediction of heart disease using risk factors. In Proceedings of the 2013 IEEE Conference on Information and Communication Technologies (pp. 1227–1231). IEEE.
https://doi.org/10.1109/CICT.2013.6558288
[11] Veerbeek, J. H. W., Hermes, W., Breimer, A. Y., van Rijn, B. B., Koenen, S. V., Mol, B. W., Franx, A., de Groot, C. J. M., & Koster, M. P. H. (2015). Cardiovascular disease risk factors after early-onset preeclampsia, late-onset preeclampsia, and pregnancy-induced hypertension. Hypertension, 65, 600–606.
https://doi.org/10.1161/HYPERTENSIONAHA.114.04850
[12] Hill, J., Hoyt, J., van Eijk, A. M., D’Mello-Guyett, L., ter Kuile, F. O., Steketee, R., Smith, H., & Webster, J. (2013). Factors affecting the delivery, access, and use of interventions to prevent malaria in pregnancy in sub-Saharan Africa: A systematic review and meta-analysis. PLoS Medicine, 10(7), e1001488.
https://doi.org/10.1371/journal.pmed.1001488
[13] Wiemer, H., Drowatzky, L., & Ihlenfeldt, S. (2019). Data mining methodology for engineering applications (DMME): A holistic extension to the CRISP-DM model. Applied Sciences, 9(12), 2407.
https://doi.org/10.3390/app9122407